Mostrando 2 resultados de: 2
Status of the neuromyelitis optica spectrum disorder in Latin America
ArticleAbstract: Background: Neuromyelitis optica spectrum disorders (NMOSD) is an increasing diagnostic and therapeuPalabras claves:diagnosis, Latin America, Neuromyelitis optica, Socioeconomic aspects, therapyAutores:Abad-Herrera P., Alonso R., Armas E., Barboza A., Becker J., Benzadón A., Bertado B., Bichuetti D.B., Bolaña C., Calderón R.F., Canabal A.P., Candelario A., Caparó-Zamalloa C., Carra A., Cedeño C.O., Céspedes J.V., Ciampi E., Contentti E.C., Cornejo E.A., Correale J., Diaz A.J., Diaz de la Fe A., Edgar Patricio Correa, Fleitas C.V., Frenk I.T., Galleguillos L., Gamarra O.G., Garcia L.A., Gracia F., Guzman M.K., Hamuy F.D.d.B., Hernández M., Lana-Peixoto M.A., Lopez E., Marques V.D., Martínez J., Molina O.M., Monterrey P., Ordoñez L., Parajeles A., Playas G., Portillo L.l., Pujol B.S., Quiñones J., Quiroz J.C.D., Raggio J.V., Ramirez D.A., Ramirez N.E., Rivas V., Rivera V.M., Rodríguez E., Rodriguez L.C., Rojas E., Rojas J.I., Sato D.K., Sinay V., Sirias V., Skromne E., Soto A., Soto I., Tavolini D.R., Villa A.M., Weiser R., Zarco L.Fuentes:scopusTherapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America
ArticleAbstract: Purpose: This study describes the therapeutic strategies in NMOSD and MOGAD adopted by neurologistsPalabras claves:Latin America, MOGAD, NMOSD, rituximab, STRATEGIES, TherapeuticAutores:Alonso R., Becker J., Bribiesca Contreras E., Caride A., Castillo I.S.d., Contentti E.C., Criniti J.M., Cristiano E., Daccach Marques V., Edgar Patricio Correa, Flores-Rivera J., Galleguillos L., Gómez-Figueroa E., Gracia F., Hamuy F.D.d.B., Jefferson Santiago Piedra-Andrade, Lana-Peixoto M.A., López P.A., Man F., María Angélica Ortiz-Yépez, Nadur D., Navas C., Patrucco L., Pettinicchi J.P., Rojas J.I., Soares Neto H.R., Tkachuk V., Toral-Granda A.M., Wilson Alfredo Gualotuña PachacamaFuentes:scopus